Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 693.35

-0.3%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (219)	2/25/1998 12:28:00 AM
From: scaram(o)uche	Read Replies (1) of 3557

MZ: Ooooh, you know something that I don't! What's the link between RGD and Tie-2? I've missed something. >>Regards the Progenitor, can they perform target validation for Del-1, or their work is oriented toward basic science (genomic) and discovery collaboration with research institutions?<< Don't know yet. Sorta looked like the embryology was from Tokyo Women's. The collaborators at Vanderbilt are top-notch, and, if you look closely at enough Medline searches, you'll even find a connection between the Vanderbilt PI and an old piece of work with the Ohio University stuff (yolk sac-derived EC). Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next